Retour
Prix Repare Therapeutics Inc (RPTX)
Graphique du cours de l'action RPTX
RPTX Dividendes
Repare Therapeutics Inc
$2.65
0.76%
$0.02
À la fermeture : Jan 27, 16:00:00 GMT-5
$2.65
0%
$0
Pré-Marché: Jan 28, 05:37:15 GMT-5
Statistiques clés
Clôture préc.
$2.63
Prix d'ouverture
$2.64
Plage de la journée
$2.62 - $2.65
Plage de 52 semaines
$0.89 - $2.66
Volume
1.1M
Volume moyen
1.1M
BPA (TTM)
-1.69
Rendement en dividend
--
Capitalisation boursière
$113.9M
Qu’est-ce que RPTX ?
Repare Therapeutics, Inc. engages in the research, development, and commercialization of precision oncology drugs targeting specific vulnerabilities of tumors in genetically defined patient populations. The company is headquartered in St-Laurent, Quebec and currently employs 129 full-time employees. The company went IPO on 2020-06-19. The firm utilizes its genome-wide, CRISPR-enabled SNIPRx platform to systematically discover and develop highly targeted cancer therapies focused on genomic instability, including DNA damage repair. Its pipeline includes RP-3467, a Phase 1 Polo ATPase inhibitor; RP-1664, a Phase 1 PLK4 inhibitor, and lunresertib, a PKMYT1 inhibitor.
Fonctionnalités
Stratégies de trading
Ressources
© 2025 Finture Development Limited. All rights reserved
